BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance

Core Insights - BrightSpring Health Services reported strong financial performance for Q4 and full year 2024, with significant revenue growth and improved profitability metrics [4][5][10] - The company anticipates a streamlined organization and enhanced growth rates following the divestiture of its Community Living business [3][5] Financial Highlights - Q4 2024 net revenue reached $3,053 million, a 28.6$2,375 million in Q4 2023 [4][6] - Q4 2024 gross profit was $422 million, up 14.4$369 million in Q4 2023 [4][6] - Q4 2024 net income was $15.4 million, compared to a net loss of$7.2 million in Q4 2023 [4][6] - Full year 2024 net revenue totaled $11,266 million, a 27.6$8,826 million in 2023 [5][6] - Full year 2024 gross profit was $1,588 million, up 10.8$1,434 million in 2023 [5][6] - Full year 2024 Adjusted EBITDA was $588 million, a 9.3$538 million in 2023 [5][6] Segment Performance - Pharmacy Solutions segment revenue for Q4 2024 was $2,397 million, a 34$1,785 million in Q4 2023 [6] - Provider Services segment revenue for Q4 2024 was $656 million, an 11$589 million in Q4 2023 [6] - Full year 2024 Pharmacy Solutions revenue was $8,754 million, a 34$6,522 million in 2023 [6] - Full year 2024 Provider Services revenue was $2,512 million, a 9$2,304 million in 2023 [6] Guidance and Future Outlook - For 2025, the company increased its revenue guidance to $11,600 –$12,100 million, reflecting a growth of 15.2% to 20.1% over 2024 [5][10] - Adjusted EBITDA guidance for 2025 is set at $545 –$560 million, indicating an 18.4% to 21.7% growth over 2024 [10]